Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS/AML cohort.

Literature DB >> 27125205

High prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS/AML cohort.

S Goel¹, J Hall², K Pradhan¹, C Hirsch³, B Przychodzen³, A Shastri¹, I Mantzaris¹, M Janakiram¹, R Battini¹, N Kornblum¹, O Derman¹, K Gritsman¹, J Al-Hafidh², Y Wang⁴, B Halmos¹, U Steidl¹, J P Maciejewski³, I Braunschweig¹, A Verma¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2016 PMID： 27125205 DOI： 10.1038/leu.2016.74

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

9 in total

1. Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.

Authors: D A Sallman; R Komrokji; C Vaupel; T Cluzeau; S M Geyer; K L McGraw; N H Al Ali; J Lancet; M J McGinniss; S Nahas; A E Smith; A Kulasekararaj; G Mufti; A List; J Hall; E Padron
Journal: Leukemia Date: 2015-10-30 Impact factor: 11.528

2. Clinical effect of point mutations in myelodysplastic syndromes.

Authors: Rafael Bejar; Kristen Stevenson; Omar Abdel-Wahab; Naomi Galili; Björn Nilsson; Guillermo Garcia-Manero; Hagop Kantarjian; Azra Raza; Ross L Levine; Donna Neuberg; Benjamin L Ebert
Journal: N Engl J Med Date: 2011-06-30 Impact factor: 91.245

3. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

Authors: Tetsuichi Yoshizato; Bogdan Dumitriu; Kohei Hosokawa; Hideki Makishima; Kenichi Yoshida; Danielle Townsley; Aiko Sato-Otsubo; Yusuke Sato; Delong Liu; Hiromichi Suzuki; Colin O Wu; Yuichi Shiraishi; Michael J Clemente; Keisuke Kataoka; Yusuke Shiozawa; Yusuke Okuno; Kenichi Chiba; Hiroko Tanaka; Yasunobu Nagata; Takamasa Katagiri; Ayana Kon; Masashi Sanada; Phillip Scheinberg; Satoru Miyano; Jaroslaw P Maciejewski; Shinji Nakao; Neal S Young; Seishi Ogawa
Journal: N Engl J Med Date: 2015-07-02 Impact factor: 91.245

4. Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.

Authors: Rafael Bejar; Kristen E Stevenson; Bennett Caughey; R Coleman Lindsley; Brenton G Mar; Petar Stojanov; Gad Getz; David P Steensma; Jerome Ritz; Robert Soiffer; Joseph H Antin; Edwin Alyea; Philippe Armand; Vincent Ho; John Koreth; Donna Neuberg; Corey S Cutler; Benjamin L Ebert
Journal: J Clin Oncol Date: 2014-08-04 Impact factor: 44.544

5. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.

Authors: Rafael Bejar; Allegra Lord; Kristen Stevenson; Michal Bar-Natan; Albert Pérez-Ladaga; Jacques Zaneveld; Hui Wang; Bennett Caughey; Petar Stojanov; Gad Getz; Guillermo Garcia-Manero; Hagop Kantarjian; Rui Chen; Richard M Stone; Donna Neuberg; David P Steensma; Benjamin L Ebert
Journal: Blood Date: 2014-09-15 Impact factor: 22.113

6. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.

Authors: Chantana Polprasert; Isabell Schulze; Mikkael A Sekeres; Hideki Makishima; Bartlomiej Przychodzen; Naoko Hosono; Jarnail Singh; Richard A Padgett; Xiaorong Gu; James G Phillips; Michael Clemente; Yvonne Parker; Daniel Lindner; Brittney Dienes; Eckhard Jankowsky; Yogen Saunthararajah; Yang Du; Kevin Oakley; Nhu Nguyen; Sudipto Mukherjee; Caroline Pabst; Lucy A Godley; Jane E Churpek; Daniel A Pollyea; Utz Krug; Wolfgang E Berdel; Hans-Ulrich Klein; Martin Dugas; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Kenichi Yoshida; Seishi Ogawa; Carsten Müller-Tidow; Jaroslaw P Maciejewski
Journal: Cancer Cell Date: 2015-04-23 Impact factor: 31.743

7. Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.

Authors: Moritz Gerstung; Andrea Pellagatti; Luca Malcovati; Aristoteles Giagounidis; Matteo G Della Porta; Martin Jädersten; Hamid Dolatshad; Amit Verma; Nicholas C P Cross; Paresh Vyas; Sally Killick; Eva Hellström-Lindberg; Mario Cazzola; Elli Papaemmanuil; Peter J Campbell; Jacqueline Boultwood
Journal: Nat Commun Date: 2015-01-09 Impact factor: 14.919

8. TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p.

Authors: M Jasek; L P Gondek; N Bejanyan; R Tiu; J Huh; K S Theil; C O'Keefe; M A McDevitt; J P Maciejewski
Journal: Leukemia Date: 2009-09-17 Impact factor: 11.528

9. Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Authors: Elli Papaemmanuil; Moritz Gerstung; Luca Malcovati; Sudhir Tauro; Gunes Gundem; Peter Van Loo; Chris J Yoon; Peter Ellis; David C Wedge; Andrea Pellagatti; Adam Shlien; Michael John Groves; Simon A Forbes; Keiran Raine; Jon Hinton; Laura J Mudie; Stuart McLaren; Claire Hardy; Calli Latimer; Matteo G Della Porta; Sarah O'Meara; Ilaria Ambaglio; Anna Galli; Adam P Butler; Gunilla Walldin; Jon W Teague; Lynn Quek; Alex Sternberg; Carlo Gambacorti-Passerini; Nicholas C P Cross; Anthony R Green; Jacqueline Boultwood; Paresh Vyas; Eva Hellstrom-Lindberg; David Bowen; Mario Cazzola; Michael R Stratton; Peter J Campbell
Journal: Blood Date: 2013-09-12 Impact factor: 22.113

9 in total

11 in total

Review 1. Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.

Authors: Miron Prokocimer; Alina Molchadsky; Varda Rotter
Journal: Blood Date: 2017-06-12 Impact factor: 22.113

Review 2. Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.

Authors: Ugo Testa; Germana Castelli; Elvira Pelosi
Journal: Mediterr J Hematol Infect Dis Date: 2022-09-01 Impact factor: 3.122

3. Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes.

Authors: Guillermo Montalban-Bravo; Rashmi Kanagal-Shamanna; Christopher B Benton; Caleb A Class; Kelly S Chien; Koji Sasaki; Kiran Naqvi; Yesid Alvarado; Tapan M Kadia; Farhad Ravandi; Naval Daver; Koichi Takahashi; Elias Jabbour; Gautham Borthakur; Naveen Pemmaraju; Marina Konopleva; Kelly A Soltysiak; Sherry R Pierce; Carlos E Bueso-Ramos; Keyur P Patel; Hagop Kantarjian; Guillermo Garcia-Manero
Journal: Blood Adv Date: 2020-02-11

4. Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome.

Authors: Yuekun Qi; Xiao Li; Chunkang Chang; Feng Xu; Qi He; Youshan Zhao; Lingyun Wu
Journal: Sci Rep Date: 2017-05-24 Impact factor: 4.379

Review 5. Regulation of Adult Neurogenesis in Mammalian Brain.

Authors: Maria Victoria Niklison-Chirou; Massimiliano Agostini; Ivano Amelio; Gerry Melino
Journal: Int J Mol Sci Date: 2020-07-09 Impact factor: 5.923

6. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.

Authors: Detlef Haase; Kristen E Stevenson; Donna Neuberg; Jaroslaw P Maciejewski; Aziz Nazha; Mikkael A Sekeres; Benjamin L Ebert; Guillermo Garcia-Manero; Claudia Haferlach; Torsten Haferlach; Wolfgang Kern; Seishi Ogawa; Yasunobu Nagata; Kenichi Yoshida; Timothy A Graubert; Matthew J Walter; Alan F List; Rami S Komrokji; Eric Padron; David Sallman; Elli Papaemmanuil; Peter J Campbell; Michael R Savona; Adam Seegmiller; Lionel Adès; Pierre Fenaux; Lee-Yung Shih; David Bowen; Michael J Groves; Sudhir Tauro; Michaela Fontenay; Olivier Kosmider; Michal Bar-Natan; David Steensma; Richard Stone; Michael Heuser; Felicitas Thol; Mario Cazzola; Luca Malcovati; Aly Karsan; Christina Ganster; Eva Hellström-Lindberg; Jacqueline Boultwood; Andrea Pellagatti; Valeria Santini; Lynn Quek; Paresh Vyas; Heinz Tüchler; Peter L Greenberg; Rafael Bejar
Journal: Leukemia Date: 2019-01-11 Impact factor: 12.883

7. Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia.

Authors: Nicholas J Short; Guillermo Montalban-Bravo; Hyunsoo Hwang; Jing Ning; Miguel J Franquiz; Rashmi Kanagal-Shamanna; Keyur P Patel; Courtney D DiNardo; Farhad Ravandi; Guillermo Garcia-Manero; Koichi Takahashi; Marina Konopleva; Naval Daver; Ghayas C Issa; Michael Andreeff; Hagop Kantarjian; Tapan M Kadia
Journal: Blood Adv Date: 2020-11-24

8. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Authors: Elsa Bernard; Yasuhito Nannya; Robert P Hasserjian; Sean M Devlin; Heinz Tuechler; Juan S Medina-Martinez; Tetsuichi Yoshizato; Yusuke Shiozawa; Ryunosuke Saiki; Luca Malcovati; Max F Levine; Juan E Arango; Yangyu Zhou; Francesc Solé; Catherine A Cargo; Detlef Haase; Maria Creignou; Ulrich Germing; Yanming Zhang; Gunes Gundem; Araxe Sarian; Arjan A van de Loosdrecht; Martin Jädersten; Magnus Tobiasson; Olivier Kosmider; Matilde Y Follo; Felicitas Thol; Ronald F Pinheiro; Valeria Santini; Ioannis Kotsianidis; Jacqueline Boultwood; Fabio P S Santos; Julie Schanz; Senji Kasahara; Takayuki Ishikawa; Hisashi Tsurumi; Akifumi Takaori-Kondo; Toru Kiguchi; Chantana Polprasert; John M Bennett; Virginia M Klimek; Michael R Savona; Monika Belickova; Christina Ganster; Laura Palomo; Guillermo Sanz; Lionel Ades; Matteo Giovanni Della Porta; Harold K Elias; Alexandra G Smith; Yesenia Werner; Minal Patel; Agnès Viale; Katelynd Vanness; Donna S Neuberg; Kristen E Stevenson; Kamal Menghrajani; Kelly L Bolton; Pierre Fenaux; Andrea Pellagatti; Uwe Platzbecker; Michael Heuser; Peter Valent; Shigeru Chiba; Yasushi Miyazaki; Carlo Finelli; Maria Teresa Voso; Lee-Yung Shih; Michaela Fontenay; Joop H Jansen; José Cervera; Yoshiko Atsuta; Norbert Gattermann; Benjamin L Ebert; Rafael Bejar; Peter L Greenberg; Mario Cazzola; Eva Hellström-Lindberg; Seishi Ogawa; Elli Papaemmanuil
Journal: Nat Med Date: 2020-08-03 Impact factor: 53.440

9. Clinical implications of subclonal TP53 mutations in acute myeloid leukemia.

Authors: Katharina T Prochazka; Gudrun Pregartner; Frank G Rücker; Ellen Heitzer; Gabriel Pabst; Albert Wölfler; Armin Zebisch; Andrea Berghold; Konstanze Döhner; Heinz Sill
Journal: Haematologica Date: 2018-10-11 Impact factor: 9.941

10. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project

Authors: Claudia Sargas; Rosa Ayala; María Carmen Chillón; María J Larráyoz; Estrella Carrillo-Cruz; Cristina Bilbao; Manuel Yébenes-Ramírez; Marta Llop; Inmaculada Rapado; Ramón García-Sanz; Iria Vázquez; Elena Soria; Yanira Florido-Ortega; Kamila Janusz; Carmen Botella; Josefina Serrano; David Martínez-Cuadrón; Juan Bergua; Mari Luz Amigo; Pilar Martínez-Sánchez; Mar Tormo; Teresa Bernal; Pilar Herrera-Puente; Raimundo García; Lorenzo Algarra; María J Sayas; Lisette Costilla-Barriga; Esther Pérez-Santolalla; Inmaculada Marchante; Esperanza Lavilla-Rubira; Víctor Noriega; Juan M Alonso-Domínguez; Miguel Á Sanz; Joaquín Sánchez-Garcia; María T Gómez-Casares; José A Pérez-Simón; María J Calasanz; Marcos González-Díaz; Joaquín Martínez-López; Eva Barragán; Pau Montesinos
Journal: Haematologica Date: 2021-12-01 Impact factor: 9.941